Vayu Global Health

What Vayu Global Health does

Vayu Global Health Innovations is a Massachusetts-incorporated public-benefit LLC founded in 2018 that designs and manufactures neonatal and pediatric respiratory care medical devices for low-resource healthcare settings. The company's two core products are the Vayu bCPAP System, a bubble Continuous Positive Airway Pressure device for newborns and infants in respiratory distress, and the Vayu Oxygen Blender System, a low-flow oxygen delivery device for adjustable oxygen concentration. Both products are architected around a venturi-based blender that operates without electricity, compressed medical air, or sophisticated biomedical engineering support, addressing the roughly 90% of global healthcare facilities that cannot access conventional CPAP systems due to cost and infrastructure constraints. The technology is protected by granted patents in the US, Canada, China, India, South Africa, and Europe, and the company holds ISO 13485:2016 certification and FDA Emergency Use Authorization for the bCPAP system.

The company sells devices directly to hospitals, national healthcare systems, and healthcare facilities globally via a quote-based B2B enterprise sales motion, with pricing positioned at a fraction of the cost of conventional $10,000+ CPAP systems. Distribution is augmented by partnerships with global health organizations including WHO/Unitaid, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the Japanese government, and by a 2022 local manufacturing partnership with Revital Healthcare to produce devices on the African continent. The company operates across more than 50 countries with regulatory clearance in nine jurisdictions (Tanzania, Kenya, Brazil, Ghana, Cambodia, Nigeria, Colombia, Ethiopia, Sierra Leone), and was co-founded by Dr. Thomas Burke, a Harvard Medical School emergency physician with 30+ years of global health experience, and Kris Joshi, a healthcare technology executive formerly CEO of Optum's $3 billion Software, Network and Data business and Norstella. Vayu is funded primarily by grants from NIH, the Gates Foundation, and Unitaid, and remains a small organization of 1-10 employees operating from Medford, Massachusetts.

Name

Vayu Global Health

Legal name

Vayu Global Health Innovations, LLC

Website

https://vayuinnovations.org

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Vayu Global Health Innovations is a Massachusetts-based medical device company developing electricity-free neonatal and pediatric respiratory care devices (bCPAP and oxygen blender systems) for hospitals and national healthcare systems in low-resource settings across more than 50 countries.

Ownership category

akta.pro rank

Product category

Neonatal Respiratory Care Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG)

Keywords

• Neonatal respiratory devices
• Bubble CPAP systems
• Medical device manufacturing
• Low-resource healthcare
• Oxygen blender devices

Headquarters

HQ city

Medford

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of Vayu bCPAP Systems and Vayu Oxygen Blender Systems to healthcare facilities, hospitals, and national healthcare systems globally. Devices are sold directly to customers with pricing based on quote requests.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Vayu Global Health Innovations designs, manufactures, and sells medical devices for neonatal and pediatric respiratory care in low-resource clinical settings. Its two core products are the Vayu bCPAP System (a bubble Continuous Positive Airway Pressure device for newborns in respiratory distress) and the Vayu Oxygen Blender System (a low-flow oxygen delivery device), both engineered to operate without electricity or compressed medical air.

Product overview

Vayu Global Health offers two core medical devices for newborn and child respiratory care: the Vayu bCPAP System (bubble CPAP for respiratory distress) and the Vayu Oxygen Blender System (oxygen blending for low-flow therapy). Both devices are designed to operate without electricity or compressed medical air, making them accessible for low-resource healthcare settings globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Vayu bCPAP System A bubble Continuous Positive Airway Pressure (CPAP) system for newborns and infants with respiratory distress. The first high-quality CPAP system that does not require electricity or compressed medical air, featuring a built-in venturi blender for adjustable oxygen concentration, humidification, and filtration. Designed for hospitals and neonatal care units in low-resource clinical settings.
• Vayu Oxygen Blender System A low-flow oxygen delivery system for newborns and young children that mixes room air with oxygen to provide adjustable oxygen concentration without the need for electricity or compressed medical air, delivered through nasal cannula. Designed for healthcare facilities in low-resource settings that require affordable, simple-to-maintain oxygen therapy equipment.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Revital HealthcarecoreOEM/ Whitelabel/ Licensing Partner · 1 January 2022Manufacturing partnership established in 2022 for local production of Vayu devices on the African continent. This partnership strengthens local supply chains, reduces distribution costs, and improves access to medical devices in Africa.
• Muhimbili National Hospital (Tanzania)coreStrategic or Co-development Partner · 1 January 2021Clinical partnership for deployment and evaluation of Vayu bCPAP Systems. Study showed treatment of over 300 patients in six months, demonstrating clinical impact.

Scale indicators4 records

Recent moves6 records

Direct peers

• SLE Limited: SLE Limited is a UK-based specialist in neonatal ventilators and CPAP systems designed specifically for premature and newborn infants. They compete directly in the neonatal respiratory device category that Vayu addresses, though with conventional power-dependent products.
• Bunnell Incorporated: Bunnell manufactures life-saving high-frequency ventilators for neonatal and pediatric patients, particularly premature infants with respiratory failure. They directly compete in the neonatal ventilation equipment category with Vayu's bubble CPAP system.
• Laerdal Global Health: Laerdal Global Health develops affordable medical devices and training products for maternal, newborn, and child health in low-resource settings. They address the same developing-country healthcare segment with a similar mission-driven, low-cost product approach.
• 3rd Stone Design (Pumani bCPAP): 3rd Stone Design developed the Pumani bubble CPAP, a low-cost neonatal respiratory device for resource-limited settings in Africa. It is the most direct competitor to Vayu bCPAP, addressing the same clinical use case with a similar electricity-independent design philosophy.
• Atom Medical Corporation: Atom Medical is a Japanese manufacturer specializing in neonatal and infant care equipment, including infant ventilators, CPAP systems, and resuscitation devices. They are a direct competitor in neonatal respiratory hardware for hospital NICUs.

Broad incumbents

• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare is a global leader in neonatal respiratory care, producing bubble CPAP circuits, interfaces, and humidification systems used in NICUs worldwide. Their premium products serve the high-end of the same neonatal respiratory market that Vayu targets.
• ResMed: ResMed is a global leader in CPAP and ventilation devices primarily for sleep apnea and respiratory care. While focused on adult sleep-disordered breathing, they possess the engineering, manufacturing, and distribution scale to enter neonatal respiratory markets.
• Drägerwerk: Dräger is a major manufacturer of neonatal ventilators, CPAP systems, and NICU infrastructure globally. They serve the same end-customers (hospital NICUs and neonatal care units) but focus on premium, electricity-dependent systems rather than low-resource settings.
• Philips Respironics: Philips Respironics is a major manufacturer of CPAP, BiPAP, and hospital ventilation systems. Although currently constrained by CPAP device recalls, they represent a large incumbent with the capacity to address neonatal respiratory markets where Vayu operates.

Emerging players

• Gradian Health Systems: Gradian Health Systems designs, distributes, and trains healthcare providers on medical equipment specifically for low-resource settings, including anesthesia and critical care devices. They serve an overlapping customer base and mission in emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vayu Global Health